Rheumatoid vasculitis is one of the most severe complications of rheumatoid arthritis. New data suggests that hydroxychloroquine and low-dose aspirin might be protective, but that there remains notable mortality despite intensive immunosuppression with cyclophosphamide or biologic agents.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Voskuyl, A. E. et al. Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case–control study. Ann. Rheum. Dis. 55, 190–192 (1996).
Makol, A. et al. Vasculitis associated with rheumatoid arthritis: a case–control study. Rheumatology (Oxford) http://dx.doi.org/10.1093/rheumatology/ket475.
Ntatsaki, E., Mooney, J., Scott, D. G. I. & Watts, R. A. Systemic rheumatoid vasculitis in the era of modern immunosuppressive therapy. Rheumatology (Oxford) 53, 145–152 (2014).
Scott, D. G. & Bacon, P. A. Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am. J. Med. 76, 377–384 (1984).
Sokumbi, O., Wetter, D. A., Makol, A. & Warrington, K. A. Vasculitis associated with tumour necrosis factor-a inhibitors. Mayo Clin. Proc. 87, 739–745 (2012).
Morris, S. J. et al. Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients. Arthritis Care Res. (Hoboken) 63, 530–534 (2011).
Bartels, C. M., Bell, C. L., Shinki, K., Rosenthal, A. & Bridges, A. J. Changing trends in serious extra-articular manifestations of rheumatoid arthritis among United State veterans over 20 years. Rheumatology (Oxford) 49, 1670–1675 (2010).
Ward, M. M. Decreases in rates of hospitalizations for manifestations of severe rheumatoid arthritis, 1983–2001. Arthritis Rheum. 50, 1122–1131 (2004).
Edwards, C. J., Campbell, J., van Staa, T. & Arden, N. K. Regional and temporal variation in the treatment of rheumatoid arthritis across the UK: a descriptive register-based cohort study. BMJ Open 2, e001603 (2012).
Puéchal, X. et al. Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the AutoImmunity and Rituximab Registry. Arthritis Care Res. (Hoboken) 64, 331–339 (2012).
Acknowledgements
R.A.W. was supported by Norfolk and Suffolk Comprehensive Research Network.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Watts, R. Rheumatoid vasculitis—down but not out. Nat Rev Rheumatol 10, 261–262 (2014). https://doi.org/10.1038/nrrheum.2014.31
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2014.31
